Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma.

[1]  R. Tubbs,et al.  Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival. , 2006, American journal of clinical pathology.

[2]  J. Delabie,et al.  Molecular cytogenetic analysis of leukemic mantle cell lymphoma with a cryptic t(11;14). , 2006, Cancer genetics and cytogenetics.

[3]  D. Catovsky,et al.  Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region. , 2004, Cancer genetics and cytogenetics.

[4]  E. Zucca,et al.  Molecular basis of mantle cell lymphoma , 2004, British journal of haematology.

[5]  J. Briones,et al.  Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14 , 2003, Journal of clinical pathology.

[6]  E. Jaffe.  Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .

[7]  L. Staudt,et al.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.

[8]  R. Gascoyne,et al.  Cytogenetic Analysis in Mantle Cell Lymphoma: A Review of 214 Cases , 2002, Leukemia & lymphoma.

[9]  S. Swerdlow,et al.  From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. , 2002, Human pathology.

[10]  F. Bosch,et al.  Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma. , 1999, Cancer genetics and cytogenetics.

[11]  F. Birg,et al.  Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. , 1999, Blood.

[12]  A. López-Guillermo,et al.  Mantle cell lymphoma , 1998, Seminars in hematology.

[13]  P. L. Bergsagel,et al.  Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. , 1999, Molecular cell.

[14]  P. Koduru,et al.  Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. , 1997, Blood.

[15]  D. Gerhard,et al.  Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. , 1996, Blood.

[16]  F. Bosch,et al.  p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. , 1996, Blood.

[17]  N. Mahmud,et al.  PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma. , 1996, Leukemia & lymphoma.

[18]  E. Schuuring,et al.  Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization. , 1996, Blood.

[19]  J. Magaud,et al.  Implication of cyclin D1 in malignant lymphoma. , 1996, Critical reviews in oncogenesis.

[20]  A. López-Guillermo,et al.  PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma , 1994 .

[21]  B. Klein,et al.  Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. , 1994, Blood.

[22]  N. Harris.  Mantle cell lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  F. Berger,et al.  Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. , 1994, Blood.

[24]  S. Swerdlow,et al.  Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. , 1993, Leukemia.

[25]  S. Gollin,et al.  Atypical (7;19) translocation in acute myelomonocytic leukemia. , 1991, Cancer genetics and cytogenetics.

[26]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .